Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. Article uri icon

Overview

publication date

  • February 24, 2020

Research

keywords

  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Purpura, Thrombocytopenic, Idiopathic
  • Receptors, Thrombopoietin

Identity

Scopus Document Identifier

  • 85083620456

Digital Object Identifier (DOI)

  • 10.1111/bjh.16426

PubMed ID

  • 32096213

Additional Document Info

volume

  • 189

issue

  • 2